Status:
TERMINATED
Genetic Susceptibility to Kidney Cancer
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
M.D. Anderson Cancer Center
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study will further the understanding of the genetic events leading to the development of RCC.
Detailed Description
This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually prov...
Eligibility Criteria
Inclusion
- Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.
Exclusion
- Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will
- Must not have had RCC, or metastatic RCC,
- Must not have had a renal transplantation
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00854022
Start Date
July 1 2008
End Date
March 1 2013
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030